TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.
TissueLabs has raised $800K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2024.
TissueLabs's investors include Innosuisse, MassChallenge Switzerland, FINEP, MIT Alumni Angels, LASP Capital.
TissueLabs is headquartered in Bellinzona, Switzerland.
TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.
TissueLabs is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TissueLabs — Funding & Investors." VCBacked, March 22, 2024, https://www.vcbacked.co/company/tissuelabs. Accessed July 19, 2026.
VCBacked. (2024). TissueLabs — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tissuelabs
{{cite web |title=TissueLabs — Funding & Investors |url=https://www.vcbacked.co/company/tissuelabs |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated